Cargando…
A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma
PURPOSE: Our study examined the effect of a selective Rho kinase inhibitor, Y-27632, on corneal wound healing and potential stromal scarring after superficial keratectomy. METHODS: Rabbit keratocytes were induced into myofibroblasts by transforming growth factor β1 (TGFβ1) either with or without Y-2...
Autores principales: | Yamamoto, Mayumi, Quantock, Andrew J., Young, Robert D., Okumura, Naoki, Ueno, Morio, Sakamoto, Yuji, Kinoshita, Shigeru, Koizumi, Noriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398489/ https://www.ncbi.nlm.nih.gov/pubmed/22815626 |
Ejemplares similares
-
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
por: Okumura, Naoki, et al.
Publicado: (2017) -
Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
por: Okumura, Naoki, et al.
Publicado: (2016) -
Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study
por: Nakagawa, Hiroko, et al.
Publicado: (2015) -
Y-27632, a ROCK Inhibitor, Promoted Limbal Epithelial Cell Proliferation and Corneal Wound Healing
por: Sun, Chi-Chin, et al.
Publicado: (2015) -
Cultivation of Corneal Endothelial Cells on a Pericellular Matrix Prepared from Human Decidua-Derived Mesenchymal Cells
por: Numata, Ryohei, et al.
Publicado: (2014)